Limitations of Current Research Many studies are preclinical Human mechanistic trials remain limited Microbiome responses vary individually Diet, sleep, stress, and medications influence outcomes GLP-1 regulation is multi-factorial The microbiome is one variable within a complex endocrine network
If body weight has reduced, running may feel smoother, and joint strain can decrease
The economics of pharmaceutical development do create real evidence gaps for unpatentable molecules, and patients pay the cost of that asymmetry
L.BelfioreA
The $11 million drug manufacturing plant in Dallas Deep Ellum neighborhood, which originally planned to start operating in late 2022, focuses on producing injectable drugs that often fall into shortages
In July, millions of people could become eligible for GLP-1 drugs that cost $50 a month under a new Medicare pilot called the Bridge program